L M Drudi1, K Phung2, M Ades2, J Zuckerman2, L Mullie3, O K Steinmetz4, D I Obrand4, J Afilalo5. 1. Division of Vascular Surgery, McGill University, Montreal, QC, Canada; Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, QC, Canada. 2. Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, QC, Canada. 3. Department of Medicine, McGill University, Montreal, QC, Canada. 4. Division of Vascular Surgery, McGill University, Montreal, QC, Canada. 5. Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, QC, Canada; Department of Medicine, McGill University, Montreal, QC, Canada; Division of Cardiology, Jewish General Hospital, Montreal, QC, Canada. Electronic address: jonathan.afilalo@mcgill.ca.
Abstract
OBJECTIVE: Psoas muscle area (PMA) is a validated surrogate for muscle mass that can be easily measured from a clinical CT scan. This study sought to determine whether PMA was associated with post-operative mortality after endovascular or open aortic aneurysm repair. METHODS: A retrospective review was undertaken of patients who underwent elective endovascular or open aortic aneurysm repair between 2010 and 2015 at a tertiary vascular center in Montreal, Quebec, Canada. Pre-operative CT scan images were analyzed with the CoreSlicer.com software tool to measure PMA at the axial level of the L4 vertebrae. Measurements were made by two independent observers blinded to clinical data. The primary endpoint was all-cause mortality. RESULTS: The cohort consisted of 149 patients with a mean age of 75.6 ± 8.8 years. The mean PMA was 24.0 ± 5.8 cm2 in males, and 14.3 ± 3.1 cm2 in females. There were 31 deaths over a mean follow-up of 22.4 months. After adjusting for age, sex, revised cardiac risk index, and surgical approach, Cox regression revealed a graded association between PMA and all-cause mortality with a hazard ratio of 0.86 per cm2 (95% CI 0.79-0.93). Addition of PMA to the model with the clinical covariates resulted in an improvement in C-statistic from 0.57 to 0.67, and BIC from 307 to 301 (with lower BIC values preferred). CONCLUSIONS: PMA is independently associated with all-cause mortality after elective endovascular and open aortic aneurysm repair, and may be integrated into the pre-operative risk assessment to optimize care in high-risk frail patients. Copyright Â
OBJECTIVE: Psoas muscle area (PMA) is a validated surrogate for muscle mass that can be easily measured from a clinical CT scan. This study sought to determine whether PMA was associated with post-operative mortality after endovascular or open aortic aneurysm repair. METHODS: A retrospective review was undertaken of patients who underwent elective endovascular or open aortic aneurysm repair between 2010 and 2015 at a tertiary vascular center in Montreal, Quebec, Canada. Pre-operative CT scan images were analyzed with the CoreSlicer.com software tool to measure PMA at the axial level of the L4 vertebrae. Measurements were made by two independent observers blinded to clinical data. The primary endpoint was all-cause mortality. RESULTS: The cohort consisted of 149 patients with a mean age of 75.6 ± 8.8 years. The mean PMA was 24.0 ± 5.8 cm2 in males, and 14.3 ± 3.1 cm2 in females. There were 31 deaths over a mean follow-up of 22.4 months. After adjusting for age, sex, revised cardiac risk index, and surgical approach, Cox regression revealed a graded association between PMA and all-cause mortality with a hazard ratio of 0.86 per cm2 (95% CI 0.79-0.93). Addition of PMA to the model with the clinical covariates resulted in an improvement in C-statistic from 0.57 to 0.67, and BIC from 307 to 301 (with lower BIC values preferred). CONCLUSIONS: PMA is independently associated with all-cause mortality after elective endovascular and open aortic aneurysm repair, and may be integrated into the pre-operative risk assessment to optimize care in high-risk frail patients. Copyright Â
Authors: Abdullah O Alenezi; Elizabeth Tai; Arash Jaberi; Andrew Brown; Sebastian Mafeld; Graham Roche-Nagle Journal: Cardiovasc Intervent Radiol Date: 2021-01-03 Impact factor: 2.740
Authors: Robert B Hawkins; J Hunter Mehaffey; Eric J Charles; John A Kern; D Scott Lim; Nicholas R Teman; Gorav Ailawadi Journal: Ann Thorac Surg Date: 2018-03-09 Impact factor: 4.330
Authors: Lisette M Vernooij; Wilton A van Klei; Karel Gm Moons; Toshihiko Takada; Judith van Waes; Johanna Aag Damen Journal: Cochrane Database Syst Rev Date: 2021-12-21
Authors: Carla M Prado; Sarah A Purcell; Carolyn Alish; Suzette L Pereira; Nicolaas E Deutz; Daren K Heyland; Bret H Goodpaster; Kelly A Tappenden; Steven B Heymsfield Journal: Ann Med Date: 2018-09-12 Impact factor: 4.709
Authors: Joshua K Kays; Tiffany W Liang; Teresa A Zimmers; Daniel P Milgrom; Hamzah Abduljabar; Andrew Young; Bradford J Kim; Teresa M Bell; Andres Fajardo; Michael P Murphy; Leonidas G Koniaris Journal: JCSM Clin Rep Date: 2018 Jan-Jun
Authors: Selcuk Adabag; Tien N Vo; Lisa Langsetmo; John T Schousboe; Peggy M Cawthon; Katie L Stone; James M Shikany; Brent C Taylor; Kristine E Ensrud Journal: J Am Heart Assoc Date: 2018-05-04 Impact factor: 5.501
Authors: Martijn S van Mourik; Yvonne C Janmaat; Floortje van Kesteren; Jeroen Vendrik; R Nils Planken; Marieke J Henstra; Juliëtte F Velu; Wieneke Vlastra; Aeilko H Zwinderman; Karel T Koch; Robbert J de Winter; Joanna J Wykrzykowska; Jan J Piek; José P S Henriques; Vincent R Lanting; Jan Baan; Corine Latour; Robert Lindeboom; M Marije Vis Journal: Catheter Cardiovasc Interv Date: 2018-09-12 Impact factor: 2.692